NAMPT and prostate cancer: In addition, NAMPT inhibitors potentiated the efficacy of the radionuclide 177Lu-DOTATATE in neuroendocrine tumors [147], and sensitized head and neck cancer and prostate cancer models to radiotherapy [186,187].